Tema Neuroscience and Mental Health ETF (MNTL) Chart & Stock Price History $24.83 -1.26 (-4.83%) (As of 11/15/2024 ET) Add Compare Share Share Chart Stock AnalysisChartHoldingsShort InterestTrends Tema Neuroscience and Mental Health ETF Stock Price Performance 5 Day Performance-7.49%1 Month Performance-9.48%3 Month PerformanceN/A6 Month Performance-2.13% Receive MNTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. MNTL Stock Chart for Sunday, November, 17, 2024 MNTL Chart by TradingView Tema Neuroscience and Mental Health ETF Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$26.09$24.83-4.83%$25.96$24.832,015 shs$10.93 million11/14/2024$26.64$26.09-2.06%$26.09$26.0922 shs$11.48 million11/13/2024$26.84$26.64-0.75%$26.64$26.6422 shs$11.72 million11/12/2024$27.29$26.84-1.65%$26.84$26.843 shs$11.81 million11/11/2024$27.31$27.29-0.07%$27.29$27.291 shs$12.01 million11/08/2024$26.97$27.31+1.25%$27.31$27.181,957 shs$12.02 million Get the Latest News and Ratings for MNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$26.87$26.97+0.38%$26.97$26.9725 shs$11.87 million11/06/2024$26.58$26.87+1.10%$26.87$26.879 shs$11.82 million11/05/2024$26.19$26.58+1.48%$26.58$26.5810 shs$11.69 million11/04/2024$26.29$26.19-0.36%$26.29$26.19714 shs$11.52 million11/01/2024$26.06$26.29+0.88%$26.29$26.294 shs$11.57 million10/31/2024$26.58$26.06-1.96%$26.06$26.064 shs$11.47 million10/30/2024$26.72$26.58-0.52%$26.62$26.58801 shs$11.70 million10/29/2024$26.79$26.72-0.26%$26.72$26.724 shs$11.76 million10/28/2024$26.57$26.79+0.85%$26.79$26.7986 shs$11.79 million10/25/2024$26.67$26.57-0.37%$26.89$26.57102 shs$11.69 million10/24/2024$26.81$26.67-0.52%$26.67$26.672 shs$11.74 million10/23/2024$27.07$26.81-0.96%$26.81$26.813 shs$11.80 million10/22/2024$27.06$27.07+0.04%$27.07$27.073 shs$11.91 million10/21/2024$27.53$27.06-1.72%$27.06$27.0655 shs$11.91 million10/18/2024$27.43$27.53+0.36%$27.53$27.539 shs$12.11 million10/17/2024$27.39$27.43+0.15%$27.43$27.4383 shs$12.05 million10/16/2024$26.99$27.39+1.48%$27.42$27.37428 shs$12.05 million Related Companies Principal Millennial Global Growth ETF Stock Chart Enact Stock Chart iShares Transition-Enabling Metals ETF Stock Chart Sprott Junior Copper Miners ETF Stock Chart iShares ESG MSCI USA Min Vol Factor ETF Stock Chart Sprott Nickel Miners ETF Stock Chart SPAC and New Issue ETF Stock Chart Global X Clean Water ETF Stock Chart Short Duration Green Bond ETF Stock Chart BNY Mellon Women's Opportunities ETF Stock Chart Receive MNTL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MNTL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.